Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.54 |
| ▸ | ADH1C | P00326 | 1/20 | 0.54 |
| ▸ | ADH1A | P07327 | 1/20 | 0.54 |
| ▸ | ADH4 | P08319 | 1/20 | 0.54 |
| ▸ | ADH7 | P40394 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14142731 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL277135 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL4603730 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL16223598 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL4660468 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL24672303 | 0.97 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL1203435 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL570864 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL3689236 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL726335 | 0.97 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2481760-B1 | INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME | CHINA PETROLEUM & CHEM CORP (CN) | 2021-05-05 | — | — | EP | claimed |
| EP-3165561-B1 | RAPID CURING THIOL EPOXY RESIN WITH IMPROVED COMPRESSION STRENGTH PERFORMANCE | BOEING CO (US) | 2021-01-13 | — | — | EP | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| EP-2980093-B1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2019-01-09 | — | — | EP | claimed |
| EP-2980092-B1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2017-10-04 | — | — | EP | claimed |
| EP-1886704-B1 | ADSORBENT AND COLUMN FOR EXTRACORPOREAL CIRCULATION | TORAY INDUSTRIES (JP) | 2016-09-28 | — | — | EP | claimed |
| EP-2265617-B1 | SOLVENTS | BIONIQS LTD (GB) | 2014-07-02 | — | — | EP | claimed |
| EP-1353989-B1 | HALOGENATED ELASTOMERIC COMPOSITIONS HAVING IMPROVED STABILITY AND GREEN STRENGTH | EXXONMOBIL CHEM PATENTS INC (US) | 2009-09-09 | — | — | EP | claimed |
| EP-1511689-B1 | SYNTHESIS OF SILICOALUMINOPHOSPHATES | EXXONMOBIL CHEM PATENTS INC (US) | 2005-12-07 | — | — | EP | claimed |
| EP-0417545-B1 | Process for the preparation of polyphenylene ether by means of selected amines | BASF AG (DE) | 1994-06-01 | — | — | EP | claimed |
| EP-0417545-A2 | Process for the preparation of polyphenylene ether by means of selected amines | BASF Aktiengesellschaft (DE) | 1991-03-20 | — | — | EP | claimed |
| US-10906921-B2 | Base generator, reagent, organic salt, composition, method for manufacturing device, cured film and device | TOYO GOSEI CO., LTD. (JP) | 2021-02-02 | — | — | US | disclosed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | disclosed |
| US-20190330247-A1 | BASE GENERATOR, REAGENT, ORGANIC SALT, COMPOSITION, METHOD FOR MANUFACTURING DEVICE, CURED FILM AND DEVICE | TOYO GOSEI CO., LTD. (JP) | 2019-10-31 | — | — | US | disclosed |
| EP-2440326-B1 | POLYSACCHARIDE MATRIX HAVING A GRAFTED POLYMER, METHOD FOR PRODUCING THE SAME AND USE THEREOF | SARTORIUS STEDIM BIOTECH GMBH (DE) | 2017-10-04 | — | — | EP | disclosed |
| US-5196138-A | Reacting alkyllithium and amines | CYPRUS FOOTE MINERAL COMPANY (US) | 1993-03-23 | — | — | US | disclosed |
| EP-0423087-A2 | Mixed lithium amides and reagent compositions thereof | CYPRUS FOOTE MINERAL COMPANY (US) | 1991-04-17 | — | — | EP | disclosed |
| EP-0417545-A2 | Process for the preparation of polyphenylene ether by means of selected amines | BASF Aktiengesellschaft (DE) | 1991-03-20 | — | — | EP | disclosed |
| US-4468526-A | Process for the preparation of thiuram disulfides | AKZONA INCORPORATED (US) | 1984-08-28 | — | — | US | disclosed |
| EP-0097232-A2 | Process for the preparation of 4-(trialkylammonium)-aceto-acetarylides | LONZA AG (CH) | 1984-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10906921-B2 | Base generator, reagent, organic salt, composition, method for manufacturing device, cured film and device | ASIC1, SEM1, RER1 | ADH1B 2785/4885ADH1C 2099/4885ADH1A 2524/4885 |
| US-20190330247-A1 | BASE GENERATOR, REAGENT, ORGANIC SALT, COMPOSITION, METHOD FOR MANUFACTURING DEVICE, CURED FILM AND DEVICE | ASIC1, SEM1, RER1 | ADH1B 2785/4885ADH1C 2099/4885ADH1A 2524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.